Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9632
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSavige, Judy Aen
dc.contributor.authorDimech, Wayneen
dc.contributor.authorFritzler, Marvinen
dc.contributor.authorGoeken, Jamesen
dc.contributor.authorHagen, E Chrisen
dc.contributor.authorJennette, J Charlesen
dc.contributor.authorMcEvoy, Roben
dc.contributor.authorPusey, Charlesen
dc.contributor.authorPollock, Wendyen
dc.contributor.authorTrevisin, Michelleen
dc.contributor.authorWiik, Allanen
dc.contributor.authorWong, Richarden
dc.date.accessioned2015-05-15T22:48:01Z
dc.date.available2015-05-15T22:48:01Z
dc.date.issued2003-09-01en
dc.identifier.citationAmerican Journal of Clinical Pathology; 120(3): 312-8en
dc.identifier.govdoc14502794en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9632en
dc.description.abstractAntineutrophil cytoplasmic antibody (ANCA) tests are used to diagnose and monitor inflammatory activity in Wegener granulomatosis, microscopic polyangiitis and its renal-limited variant (pauci-immune crescentic glomerulonephritis), and Churg-Strauss syndrome. The International Consensus Statement on testing and reporting of ANCA states that ANCA are demonstrated most readily in these conditions by using a combination of indirect immunofluorescence (IIF) of normal peripheral blood neutrophils and enzyme-linked immunosorbent assays (ELISAs) that detect ANCA specific for proteinase 3 or myeloperoxidase. The group that produced the International Consensus Statement has developed guidelines for the corresponding quality control activities, examples of comments for various IIF patterns and ELISA results, and recommendations for ANCA testing when inflammatory bowel disease and other nonvasculitic ANCA-associated autoimmune diseases are suspected.en
dc.language.isoenen
dc.subject.otherAntibodies, Antineutrophil Cytoplasmic.blooden
dc.subject.otherAutoimmune Diseases.diagnosisen
dc.subject.otherEnzyme-Linked Immunosorbent Assayen
dc.subject.otherFluorescent Antibody Techniqueen
dc.subject.otherHumansen
dc.subject.otherQuality Controlen
dc.titleAddendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.en
dc.typeJournal Articleen
dc.identifier.journaltitleAmerican journal of clinical pathologyen
dc.identifier.affiliationUniversity of Melbourne, Department of Medicine, Austin and Repatriation Medical Centre, Heidelberg, VIC 3084, Australiaen
dc.identifier.doi10.1309/WAEP-ADW0-K4LP-UHFNen
dc.description.pages312-8en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/14502794en
dc.contributor.corpauthorInternational Group for Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.